• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioInvent International AB

+ Add to Watchlist


2.9900 SEK 0.0100 0.33%

As of 11:29:59 ET on 04/23/2014.

Snapshot for BioInvent International AB (BINV)

Open: 2.9900 Day's Range: 2.9700 - 3.0300 Volume: 268,777
Previous Close: 3.0000 52wk Range: 1.7889 - 4.6418 1-Yr Rtn: +13.42%

Stock Chart for BINV

No chart data available.
  • BINV:SS 2.9900
  • 1D
  • 1M
  • 1Y
Interactive BINV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BINV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.2542
Est. EPS (SEK) (12/2014) -0.2930
Est. PEG Ratio -
Market Cap (M SEK) 317.74
Shares Outstanding (M) 106.27
30 Day Average Volume 354,256
Price/Book (mrq) 5.5090
Price/Sale (ttm) 3.1416
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BINV

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BINV

BioInvent International AB is a research and development company within biotechnology. The Company has created human antibody libraries that can be used in a broad range of applications. BioInvent delivers proteins to drug and biotechnology companies, grants licenses for use of its libraries, and establishes partnerships to develop and manufacture protein based drugs.

Martin WilesSenior VP:Business DevelopmentBjoern FrendeusVP:Preclinical Research
Per-Anders JohanssonVP:Quality AssuranceMagnus KorsgrenDirector:Medical
More Company Profile & Key Executives for BINV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil